84 related articles for article (PubMed ID: 8034487)
1. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening.
Isacsohn M; Bar On E; Yaeger Y; Smetana Z; Weiner D; Slater PE
Isr J Med Sci; 1994; 30(5-6):379-83. PubMed ID: 8034487
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
[TBL] [Abstract][Full Text] [Related]
3. Selected epidemiological features of herpes genitalis in Israel based on laboratory data.
Smetana Z; Dulitzky M; Movshovitz M; Isacsohn M; Seidman D; Leventon-Kriss S
Isr J Med Sci; 1994; 30(5-6):375-9. PubMed ID: 8034486
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
Ross SE; Carter B; Lambert S
Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
[TBL] [Abstract][Full Text] [Related]
5. Screening of Herpes simplex virus 2 infection among pregnant women in southern China.
Li JM; Chen YR; Li XT; Xu WC
J Dermatol; 2011 Feb; 38(2):120-4. PubMed ID: 21269306
[TBL] [Abstract][Full Text] [Related]
6. The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women.
Isacsohn M; Dolberg L; Sabag SG; Mitrani-Rosenbaum S; Nubani N; Diamant YZ; Goldsmidt R
Isr J Med Sci; 1994; 30(5-6):383-7. PubMed ID: 8034488
[TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City].
Conde-González CJ; Lazcano-Ponce E; Hernández-Girón C; Juárez-Figueroa L; Smith JS; Hernández-Avila M
Salud Publica Mex; 2003; 45 Supp 5():S608-16. PubMed ID: 14974271
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel.
Davidovici BB; Green M; Marouni MJ; Bassal R; Pimenta JM; Cohen D
J Infect; 2006 May; 52(5):367-73. PubMed ID: 16213591
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States.
Xu F; Markowitz LE; Gottlieb SL; Berman SM
Am J Obstet Gynecol; 2007 Jan; 196(1):43.e1-6. PubMed ID: 17240228
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
11. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.
Uusküla A; Nygard-Kibur M; Cowan FM; Mayaud P; French RS; Robinson JN; Brown DW
Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398
[TBL] [Abstract][Full Text] [Related]
12. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area.
LeGoff J; Saussereau E; Boulanger MC; Chemin C; Si-Mohamed A; Bélec L; Maisonneuve L
Int J STD AIDS; 2007 Sep; 18(9):593-5. PubMed ID: 17785000
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
Slomka MJ
Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
[TBL] [Abstract][Full Text] [Related]
14. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
[TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus type 1 and 2 in Switzerland].
Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
[TBL] [Abstract][Full Text] [Related]
17. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing.
Lafferty WE
Herpes; 2002 Jul; 9(2):51-5. PubMed ID: 12106513
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel.
Feldman PA; Steinberg J; Madeb R; Bar G; Nativ O; Tal J; Srugo I
Isr Med Assoc J; 2003 Sep; 5(9):626-8. PubMed ID: 14509150
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies against Herpes simplex virus type 2 among pregnant women in Norway].
Eskild A; Jeansson S; Jenum PA
Tidsskr Nor Laegeforen; 1999 Jun; 119(16):2323-6. PubMed ID: 10414195
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients.
Perkins NL; Coughlan EP; Franklin RA; Reid MR; Taylor J
N Z Med J; 1996 Oct; 109(1032):402-5. PubMed ID: 8937391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
